Navigation Links
Howard Goldstein Joins Microchip Biotechnologies, Inc. as Executive Vice President
Date:12/1/2009

PLEASANTON, Calif., Dec. 1 /PRNewswire/ -- The new position of Executive Vice President, Commercial Affairs at Microchip Biotechnologies, Inc. has been taken up by Howard Goldstein, a biotech lab systems executive with more than 30 years of experience creating and managing life science product organizations. Mr. Goldstein will direct Microchip Biotechnologies' marketing, business development, sales and customer service operations as the company makes the transition from product development to full commercial operations.

"Howard adds directly relevant strategic, operational, and commercial experience to our executive profile," said Stevan Jovanovich, President/CEO of Microchip Biotechnologies. "His leadership and expertise will be keys to the realization of our commercial growth objectives."

Prior to joining Microchip Biotechnologies, Mr. Goldstein first served as Chief Executive Officer and then Chief Commercial Officer of Arcxis Biotechnologies, and was Managing Partner of Practical Marketing and Sales, a biotech business consultancy. He has been responsible for building and directing marketing, engineering, and sales teams that have created more than 10 key product categories in the research marketplace. Mr. Goldstein received his MBA degree in Organizational Development from Temple University, Philadelphia, PA and an M.Sc. degree in Biochemistry from the University of Dayton, Dayton OH.

About Microchip Biotechnologies, Inc.

Microchip Biotechnologies, Inc. (MBI), headquartered in Pleasanton, CA is a venture-backed, privately held company that produces automated sample processing systems for life sciences, applied sciences, and healthcare diagnostics markets. The company's products are based on the Apollo fluidics technology platform, which integrates advanced fluidics and analytical capabilities to produce automated sample-to-answer systems for DNA and RNA sequencing, DNA-based forensics and human identity (HID) testing, biodefense, and molecular diagnostics applications. The company's first product, the Apollo 100 System, automates sample processing for Sanger cycle sequencing and dramatically reduces process requirements for expensive sequencing reagents. For additional information about MBI, visit http://www.microchipbiotech.com.


Contact: Howard D. Goldstein
Microchip Biotechnologies Inc.
5720 Stoneridge Drive, Suite 300
Pleasanton, CA 94568
(925) 701-3481
howard.goldstein@microchipbiotech.com

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.

SOURCE Microchip Biotechnologies, Inc.


'/>"/>
SOURCE Microchip Biotechnologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Scott Glenn Joins Exagen Diagnostics as Chairman and CEO
2. PFC Pharma Joins DATATRAKs CRO Connect Program
3. William Cork Joins Fenwal as Chief Technology Officer
4. Jeffrey Trotter Joins Pharmanet Development Group as Executive Vice President, Phase IV Development
5. Dr. Harry Kovelman Joins Ferring Pharmaceuticals as Associate Medical Director for Orthopaedics
6. American Lung Association of California Joins Sheriffs Department to Support Influenza Vaccination In Sacramento
7. Marsha Fanucci Joins Ironwood Board of Directors
8. Dr. Mahdi B. Fawzi Joins Warner Chilcott as President, Global Research and Development
9. The Medco Foundation Joins With the Entertainment Industry Foundation to Give Health a Hand to Communities in Need
10. Dilon Diagnostics Joins Forces With Philips for Womens Health Solutions
11. Amarex Clinical Research Selects OmniComm Systems to Provide eClinical Solutions for Phase III Medical Device Study and Joins OmniComms CRO Preferred Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... DUBLIN , Dec 8, 2016 Research ... Electrodes Market Analysis and Trends - Adhesion Type, Application, Usability - ... ... The Global Cardiology Electrodes Market is poised to grow at a ... prominent trends that the market is witnessing include advancements in extracellular ...
(Date:12/8/2016)... 8, 2016 Bodycad announced it has ... the accuracy, reproducibility and speed for 3D constructs ... small bone orthopaedic applications. These patents are critical ... orthopaedic restorations based on each patient,s distinct anatomy. ... company harnesses the world,s first suite of orthopaedic ...
(Date:12/8/2016)... Dec. 8, 2016  A new study by a ... use of opioid therapy to treat chronic pain is ... of more harmful consequences, including death. Palliative ... Zankhana Mehta , M.D., authored the study which ... opioid therapy. The study was published in the December ...
Breaking Medicine Technology:
(Date:12/9/2016)... ... December 09, 2016 , ... Flottman Company ... outserts. As a means of expanding capabilities Flottman has added a G&K ... individually code professional inserts (PIs) and patient package inserts (PPIs) that will marry ...
(Date:12/9/2016)... ... December 09, 2016 , ... The Justin Veatch Fund announced Thursday ... recommending the film Whispering Spirits and its discussion guide for use by ... education tool in the war against teen drug abuse. NCADD is the oldest ...
(Date:12/9/2016)... ... December 09, 2016 , ... An inventor from Cana, Va., wanted to fulfill ... of amusement park rides. , The patent-pending SAFETY STRAP FOR AMPUTEES improves accessibility. It ... could be set up in a matter of minutes, or even seconds. The SAFETY ...
(Date:12/9/2016)... Lee, NJ (PRWEB) , ... December 09, 2016 ... ... 2016 Founders Ball at The Pierre Hotel in New York, NY, on December ... friends, benefactors, dignitaries and physicians attended the annual event, which raised over $1 ...
(Date:12/9/2016)... ... , ... "I had a terrible time trying to get my grandson to ... the nebulizer had a more child-friendly design, then children would be more likely to ... NEBY to avoid the need to deliver medication via a nebulizer mask. The design ...
Breaking Medicine News(10 mins):